International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Postmarket Study
Clinical Ophthalmology · 2024-02 · Volume 18 · 525-536
DOI: 10.2147/opth.s435581 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Ophthalmology, 2024-02. Verfasst von Anastasios John Kanellopoulos und 6 weiteren Autor:innen. Beteiligte Einrichtung: LaserVision Ambulatory Surgical Unit, Athens, Greece. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Purpose
To assess the safety and efficacy of a customized ablation treatment (InnovEyes) to correct myopia and myopic astigmatism with femtosecond laser-assisted in situ keratomileusis (Femto LASIK). Patients and Methods: In this prospective, nonrandomized, multicenter study, 113 patients (225 eyes) with preoperative myopia less than -9.0 diopters (D) and astigmatism 0 to -4.0 D (based on InnovEyes refraction) underwent wavefront, tomography, and biometry assessment using a single diagnostic device (InnovEyes sightmap). These data were imported and used unmodified by the InnovEyes algorithm to automatically calculate and optimize correction of lower- and higher‑order aberrations (HOAs) treated by the EX500 ablation profile. Visual acuity, refractive error, HOAs, and patient satisfaction were evaluated over 3 months.
Results
A total of 106 patients (212 eyes) completed the study and were included in the analysis. Mean preoperative manifest refraction spherical equivalent (MRSE) was -3.38±1.76 D. At Month 3, uncorrected distance visual acuity was 20/20 or better in 208/212 (98.1%) eyes, and it was the same as, or better than, the preoperative best-corrected distance visual acuity (CDVA) in 162/212 (76.4%) eyes; 76/212 (35.8%) eyes gained ≥1 line of CDVA. MRSE was within ±0.5 D in 195/212 (92.0%) eyes. Additionally, 201/209 (96.2%) eyes had no change (defined as a change between -0.1 μm and 0.1 μm, inclusive) in HOAs, and 105/106 (99.1%) patients reported to be satisfied with the results.
Conclusion
Customizing ray-tracing Femto LASIK with this platform appeared safe and effective in correcting myopic astigmatism and also achieved a significant percentage of eyes gaining lines of vision, potentially by addressing HOAs, along with a consistently high level of patient satisfaction.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- LaserVision Ambulatory Surgical Unit, Athens, Greece.
- Department of Ophthalmology, NYU Grossman School of Medicine, New York City, NY, USA.
- Sehkraft Augenzentrum, Köln, Germany.
- PersonalEyes, Sydney, NSW, Australia.
- Alcon Vision, LLC, Fort Worth, TX, USA.
- Alcon Deutschland GmbH, Freiburg, Germany.
ORCID-Profile: Anastasios John Kanellopoulos, Chandra Bala, Ramin Khoramnia
Zitieren
APA
Kanellopoulos, A. J., Maus, M., Bala, C., Hamilton, C., Lemonis, S., Jockovich, M. E., & Khoramnia, R. (2024). International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Postmarket Study. Clinical Ophthalmology, Volume 18, 525-536. https://doi.org/10.2147/opth.s435581
Vancouver
Kanellopoulos AJ, Maus M, Bala C, Hamilton C, Lemonis S, Jockovich ME, et al. International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Postmarket Study. Clinical Ophthalmology. 2024;Volume 18:525-536. doi:10.2147/opth.s435581
BibTeX
@article{Kanellopoulos2024,
author = {Kanellopoulos, Anastasios John and Maus, Matthias and Bala, Chandra and Hamilton, Cody and Lemonis, Sissimos and Jockovich, Maria Elena and Khoramnia, Ramin},
title = {International Multicenter, Myopic and Myopic Astigmatism Femto LASIK, Customized by Automated Ray-Tracing Ablation Profile Calculation: A Postmarket Study},
journal = {Clinical Ophthalmology},
year = {2024},
volume = {Volume 18},
pages = {525--536},
doi = {10.2147/opth.s435581}
}
EUVIMED